104 related articles for article (PubMed ID: 21993571)
1. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer.
Yamashita S; Masuda Y; Matsumoto K; Okumura Y; Matsuzaki H; Kurizaki T; Haga Y; Katafuchi S; Murayama T; Ikei S; Kawahara K
Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):236-9. PubMed ID: 17717498
[TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
4. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
5. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
6. PRL PTPs: mediators and markers of cancer progression.
Bessette DC; Qiu D; Pallen CJ
Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
[TBL] [Abstract][Full Text] [Related]
7. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
8. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
Han S; Sidell N; Roman J
Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
[TBL] [Abstract][Full Text] [Related]
10. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
12. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K
Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
Huang QM; Tomida S; Masuda Y; Arima C; Cao K; Kasahara TA; Osada H; Yatabe Y; Akashi T; Kamiya K; Takahashi T; Suzuki M
Cancer Res; 2010 Nov; 70(21):8407-16. PubMed ID: 20861182
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
